Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:KANG

iKang Healthcare Group (KANG) Stock Price, News & Analysis

iKang Healthcare Group logo

About iKang Healthcare Group Stock (NASDAQ:KANG)

Advanced Chart

Key Stats

Today's Range
$20.52
$20.55
50-Day Range
N/A
52-Week Range
$15.27
$21.01
Volume
306,806 shs
Average Volume
154,054 shs
Market Capitalization
$1.43 billion
P/E Ratio
89.26
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

iKang Healthcare Group, Inc., together with its subsidiaries, provides preventive healthcare solutions in the People's Republic of China. It operates in two segments, Medical Examinations, and Other Medical Services and Dental Services. The company offers a range of medical examinations, including internal, gynecology, ophthalmology, ENT, dental, lab test, electrocardiogram, ultrasound, and X-ray examination items. It also provides value-added services at various medical centers, such as disease screening focusing on cancer screening, cardiovascular disease screening, certain chronic disease screening, and functional medicine testing; dental care comprising oral health, pediatric dentistry, cosmetic dentistry, orthodontics, and dental implants; outpatient services that include acupuncture, Chinese medicine, gynecology, internal medicine, obstetrics, ophthalmology, pediatrics, urology, and minor surgery; and on-site healthcare management or clinical services. The company primarily serves corporate and individual customers through a network of self-owned medical centers and the facilities of third-party service providers. As of July 16, 2018, it had a network of 113 self-owned medical centers in 33 cities of China, which comprise Beijing, Shanghai, Guangzhou, Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou, Chengdu, Fuzhou, Jiangyin, Changzhou, Wuhan, Changsha, Yantai, Yinchuan, Weihai, Weifang, Shenyang, Xi'an, Wuhu, Guiyang, Ningbo, Foshan, Jinan, Bijie, Qingdao, Wuxi, Kaili, Mianyang, and Zhenjiang, as well as Hong Kong; and approximately 400 third-party facilities. The company was formerly known as China iKang Healthcare, Inc. and changed its name to iKang Healthcare Group, Inc. in February 2014. iKang Healthcare Group, Inc. is headquartered in Beijing, the People's Republic of China. As of August 14, 2018, iKang Healthcare Group, Inc. was taken private.

Receive KANG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iKang Healthcare Group and its competitors with MarketBeat's FREE daily newsletter.

KANG Stock News Headlines

Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
IHH Healthcare’s Shareholder EPF Adjusts Stock Holdings
See More Headlines

KANG Stock Analysis - Frequently Asked Questions

iKang Healthcare Group, Inc. (NASDAQ:KANG) posted its quarterly earnings results on Wednesday, August, 31st. The medical research company reported $0.04 earnings per share (EPS) for the quarter. The medical research company had revenue of $101.20 million for the quarter. iKang Healthcare Group had a negative net margin of 2.88% and a positive trailing twelve-month return on equity of 4.25%.

Based on aggregate information from My MarketBeat watchlists, some other companies that iKang Healthcare Group investors own include Garmin (GRMN), Madrigal Pharmaceuticals (MDGL), Novo Nordisk A/S (NVO), Bausch Health Companies (BHC), Bristol-Myers Squibb (BMY), Catalyst Pharmaceuticals (CPRX) and Depomed (DEPO).

Company Calendar

Last Earnings
8/31/2016
Today
5/19/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Offices & Clinics Of Medical Doctors
Sub-Industry
N/A
Current Symbol
NASDAQ:KANG
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
89.26
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-17,300,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$563.93 million
Cash Flow
$0.86 per share
Price / Cash Flow
23.88
Book Value
$5.47 per share
Price / Book
3.75

Miscellaneous

Free Float
N/A
Market Cap
$1.43 billion
Optionable
Optionable
Beta
-0.13
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:KANG) was last updated on 5/20/2025 by MarketBeat.com Staff
From Our Partners